Use of Pulmonary Inhalants Remains Remarkably High After Atrial Septal Defect Closure

Martina Nassif, Odilia I Woudstra, Joey M Kuijpers, Peter J Sterk, Reindert P van Steenwijk, Aeilko H Zwinderman, Berto J Bouma, Robbert J de Winter

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Post-repair atrial septal defects (ASD) patients are frequently discharged from follow-up, but the extent of pulmonary symptoms long-term post-repair is unknown. Methods and Results: The national CONgenital CORvitia registry was linked to the national Drug Registry to investigate all ambulatory-dispensed pulmonary inhalants for 2006–2014. ASD patients were compared with age-and sex-matched referents from the general population. A total of 1,959 adult patients (age 42±17 years; 66% female; 1,223 [62%] repaired) were included. Compared with the referents, ASD patients had more inhalant use, even at long-term post-repair follow-up (OR=1.81 [95% CI 1.62–2.03]; P<0.001). Conclusions: ASD patients had 2-fold higher inhalant use compared with referents even at long-term post-repair follow-up, suggesting persistent pulmonary functional impairment.

Original languageEnglish
Pages (from-to)2913-2916
Number of pages4
JournalCirculation journal
Volume82
Issue number11
DOIs
Publication statusPublished - 25 Oct 2018

Keywords

  • Administration, Inhalation
  • Adult
  • Female
  • Follow-Up Studies
  • Heart Septal Defects/complications
  • Humans
  • Lung
  • Lung Diseases/complications
  • Male
  • Middle Aged
  • Registries

Fingerprint

Dive into the research topics of 'Use of Pulmonary Inhalants Remains Remarkably High After Atrial Septal Defect Closure'. Together they form a unique fingerprint.

Cite this